Setting your location helps us to show you nearby providers and locations based on your healthcare needs.
Your Location is set to Change My Location
Cone Health wants to help you get well and stay well. This section provides tools and information to achieve good health and maintain your well-being.
Learn what community resources are available to help you get well and stay well.
View health and wellness news you can use from Cone Health providers on
View Advanced Search OptionsView All Doctors
View All Locations
Home > Patient & Family Resources > Health Library > Hepatitis B Treatment Recommendations
COVID-19 Info: Vaccines (5 & up) | Boosters | Testing | Visitor Guidelines | Stats | More
IMPORTANT NOTICE: COVID-19 testing appointments are not available at Cone Health emergency departments or urgent care locations. Click here for testing options.
The American Association for the Study of Liver Disease has made recommendations for treating long-term (chronic) hepatitis B. These recommendations are based on the presence of hepatitis B antigens in your blood, the level of hepatitis B viral DNA ( HBV DNA) in your blood, and the level of the liver enzyme alanine aminotransferase (ALT).
Chronic hepatitis B can be HBeAg-positive or -negative. This means a specific hepatitis B antigen (HBeAg) is present (positive) or is not present (negative) in your blood. High levels of HBV DNA and liver enzymes may be present in both of these types of chronic hepatitis. This points to an active viral infection and increased risk of liver damage.
Treatment with antiviral medicine is recommended if you are:footnote 1
Treatment with antiviral medicine is not recommended if you are:footnote 1
If you are either HBeAg-positive or -negative, have low levels of HBV DNA, and have cirrhosis, you may be monitored or may need a liver transplant.
The European Association for the Study of the Liver (EASL) also has guidelines for the treatment of chronic hepatitis B. According to the EASL, treatment should be considered for people with high levels of HBV DNA and/or higher-than-normal levels of the liver enzyme ALT, and moderate to severe liver inflammation. But the decision to treat should also consider a person's general health, age, and availability of antiviral medicines.footnote 2
Terrault NA, et al. (2016). AASLD guidelines for treatment of chronic hepatitis B. Hepatology, 63(1): 261–283. DOI: 10.1002/hep.28156. Accessed May 21, 2018.
European Association for the Study of the Liver (2012). EASL Clinical Practice Guidelines: Management of chronic hepatitis B. Journal of Hepatology, 57(1): 167–185.
Current as of:
July 1, 2021
Author: Healthwise StaffMedical Review: Kathleen Romito MD - Family MedicineAdam Husney MD - Family MedicineW. Thomas London MD - Hepatology
Current as of: July 1, 2021
Author: Healthwise Staff
Medical Review:Kathleen Romito MD - Family Medicine & Adam Husney MD - Family Medicine & W. Thomas London MD - Hepatology
To learn more about Healthwise, visit Healthwise.org.
© 1995-2021 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
Subscribe to our Wellness Matters e-newsletter, a monthly snapshot of the some of great wellness content from Cone Health providers.